Citations

Clear

1315 citation(s) found for "Kyle, RA".

Reduction of Postoperative Hip Arthroscopy Pain With an Ultrasound-Guided Fascia Iliaca Block: A Prospective Randomized Controlled Trial
Glomset, John Larson, Tokish, John M. , Renfro, Suzanne D., Seckel, Tyler B., Adams, Kyle J. , Folk, Jason, Kim, Eugene S.

Mayo Clinic

The American Journal of Sports Medicine | January 30, 2020 | Volume: 48 | Issue: 3 | Pages: 682-688

10.1177/0363546519898205 | PMID 31999469 Get It

Background: Ultrasound-guided fascia iliaca blocks have been used for pain control after hip arthroscopy. There is little evidence regarding their effectiveness in comparison with other pain control modalities in patients who have undergone hip arthroscopy. Purpose: To compare the efficacy of ultrasound-guided fascia iliac block with intra-articular ropivacaine in controlling pain after hip arthroscopy. Study Design: Randomized controlled trial; Level of evidence, 2. Methods: Between 2015 and 2017, patients (N = 95) undergoing hip arthroscopy were randomly assigned to 2 groups. The first group received an ultrasound-guided fascia iliaca block with 50 to 60 mL of 0.35% ropivacaine. The second group received an intra-articular injection of 20 mL of 0.5% ropivacaine at the completion of the surgical case. Primary outcomes were postoperative pain scores in the recovery room; at postanesthesia care unit (PACU) discharge; and at 2 weeks, 6 weeks, and 3 months. Secondary outcomes included intraoperative and PACU narcotic usage (converted to morphine equivalent use) as well as readmission rates, PACU recovery time, and postoperative nausea and vomiting. Results: Postoperative pain across all points did not significantly differ between the groups. Intraoperative and PACU narcotics did not differ significantly between the groups. Readmission rates, PACU recovery time, and postoperative nausea and vomiting did not significantly differ between the groups. There were no associated complications in either group. Conclusion: Ultrasound-guided fascia iliaca block for hip arthroscopy had no clinical advantage when compared with onetime intra-articular ropivacaine injection. Registration: NCT02365961 (ClinicalTrials.gov identifier).
The Clinical Effect of an Early, Protocolized Approach to Mechanical Ventilation for Severe and Refractory Hypoxemia
Holets, Steven R, Tescher, Ann, Elmer, Jennifer, Arteaga, Grace M. , Schears, Gregory J. , Patch, Richard K. , Bohman, J. Kyle , Oeckler, Richard A. , Tescher, Ann N, Schears, Gregory, Bohman, John K., Bohman, John K , Moraes, Alice Gallo de

Mayo Clinic

Respiratory Care | January 28, 2020 | Volume: 65 | Issue: 4 | Pages: 413-419

10.4187/respcare.07243 | PMID 31992664 Get It

BACKGROUND: ARDS remains a source of significant morbidity and mortality in the critically ill patient. The mainstay of therapy entails invasive mechanical ventilation utilizing a lung-protective strategy designed to limit lung injury associated with excessive stress and strain while the underlying etiology of respiratory failure is identified and treated. Less is understood about what to do once conventional ventilation parameters have been optimized but the patient's respiratory status remains unchanged or worsens. In 2015, a protocolized, stepwise approach to mechanical ventilation with partially automated and clearly defined thresholds for management changes was implemented at our institution. We hypothesized that, by identifying appropriate patients earlier, time-to-escalation and rescue therapy implementation would be shortened. METHODS: Subjects with severe ARDS, treated with prone positioning based on our institution's protocolized approach from December 2013 to August 2016 were included. Their baseline characteristics, severity of illness scores, and mechanical ventilation parameters were collected and analyzed. RESULTS: Baseline characteristics, tidal volumes, P aO 2 / F IO 2 , duration of ventilation after proning, and mortality were similar in both groups. Median (interquartile range [IQR]) PEEP at the time of proning was higher after the protocol implementation (12.5 cm H 2 O [IQR 6.5–19.4] vs 18 cm H 2 O [IQR 10–22], P = .386), and mean (IQR) respiratory system driving pressure was lower (16 cm H 2 O [IQR 13–36.2] vs 12 cm H 2 O [IQR 9–19.6], P = .029). Median (IQR) time from refractory hypoxemia identification to proning was shorter after protocol implementation (42.2 h [IQR 6.83–347.2] vs 16.3 h [IQR 1–99.7], I = .02), and P aO 2 / F IO 2 at 1 h after proning was higher. ICU and hospital LOS were shorter after the protocol implementation. CONCLUSIONS: Following the implementation of an early, evidence-based, protocolized approach to optimizing mechanical ventilation, subjects with true refractory hypoxemia were identified earlier and time to proning was significantly shorter. Despite improvement in the evaluation and management of refractory hypoxemia as well as time to initiation of prone positioning, mortality was unchanged and there was variation in the duration of the position.
Utility of serum free light chain ratio in response definition in patients with multiple myeloma
Abdallah, Nadine , Kapoor, Prashant , Murray, David , Buadi, Francis K. , Dingli, David , Gertz, Morie A. , Hayman, Suzanne R. , Kourelis, Taxiarchis , Lacy, Martha Q. , Lust, John A., Muchtar, Eli , Warsame, Rahma , Kyle, Robert A. , Kumar, Shaji , Gertz, Morie A , Muchtar, E , Buadi, Francis K , Dingli, David , Dispenzieri, Angela , Go, Ronald S. , Gonsalves, Wilson I. , Leung, Nelson , Rajkumar, S. Vincent

Mayo Clinic

Blood Advances | January 24, 2020 | Volume: 4 | Issue: 2 | Pages: 322-326

10.1182/bloodadvances.2019001099 | PMID 31978213 Get It

Key PointsPatients with an abnormal sFLC ratio because of LC suppression have outcomes similar to those with a normal ratio. sFLC ratio has prognostic value in patients achieving CR who have an absence of clonal BMPCs assessed by MFC.
Serum Reference Intervals and Diagnostic Ranges for Free κ and Free λ Immunoglobulin Light Chains: Relative Sensitivity for Detection of Monoclonal Light Chains
Katzmann, Jerry A., Clark, Raynell, Abraham, Roshini S. , Bryant, Sandra C. , Lymp, James, Kyle, Robert A. , Bradwell, A.R.

Mayo Clinic

Clinical Chemistry | January 24, 2020 | Volume: 48 | Issue: 9 | Pages: 1437-1444

10.1093/clinchem/48.9.1437 Get It

AbstractBackground: The detection of monoclonal free light chains (FLCs) is an important diagnostic aid for a variety of monoclonal gammopathies and is especially important in light-chain diseases, such as light-chain myeloma, primary systemic amyloidosis, and light-chain-deposition disease. These diseases are more prevalent in the elderly, and assays to detect and quantify abnormal amounts of FLCs require reference intervals that include elderly donors.Methods: We used an automated immunoassay for FLCs and sera from a population 21–90 years of age. We used the calculated reference and diagnostic intervals to compare FLC results with those obtained by immunofixation (IFE) to detect low concentrations of monoclonal κ and λ FLCs in the sera of patients with monoclonal gammopathies.Results: Serum κ and λ FLCs increased with population age, with an apparent change for those >80 years. This trend was lost when the FLC concentration was normalized to cystatin C concentration. The ratio of κ FLC to λ FLC (FLC K/L) did not exhibit an age-dependent trend. The diagnostic interval for FLC K/L was 0.26–1.65. The 95% reference interval for κ FLC was 3.3–19.4 mg/L, and that for λ FLC was 5.7–26.3 mg/L. Detection and quantification of monoclonal FLCs by nephelometry were more sensitive than IFE in serum samples from patients with primary systemic amyloidosis and light-chain-deposition disease.Conclusions: Reference and diagnostic intervals for serum FLCs have been developed for use with a new, automated immunoassay that makes the detection and quantification of monoclonal FLCs easier and more sensitive than with current methods. The serum FLC assay complements IFE and allows quantification of FLCs in light-chain-disease patients who have no detectable serum or urine M-spike.
Trimolecular Complexes of λ Light Chain Dimers in Serum of a Patient with Multiple Myeloma
Abraham, Roshini S. , Charlesworth, M. Cristine , Owen, Barbara, Benson, Linda M., Katzmann, Jerry A., Reeder, Craig B. , Kyle, Robert A. , Charlesworth, M. Cristine , Owen, Barbara AL

Mayo Clinic

Clinical Chemistry | January 24, 2020 | Volume: 48 | Issue: 10 | Pages: 1805-1811

10.1093/clinchem/48.10.1805 Get It

AbstractBackground: Patients with multiple myeloma often have Bence Jones proteins composed of free monoclonal light chains of the κ or λ type in their urine. Usually, these light chains exist as monomeric or dimeric forms, but rarely, larger molecules, such as tetramers, have been reported in the serum.Methods and Results: We report the presence of trimeric complexes of λ light chain dimers in a patient who was diagnosed with a free λ light chain multiple myeloma 2 years earlier and subsequently underwent a stem cell transplant. Recently, the patient presented with a large serum M-spike (23 g/L) by protein electrophoresis. The spike consisted of monoclonal λ light chains without a heavy chain. The urine contained only 8 mg of λ light chain in a 24-h specimen. Quantitative analysis of the serum and urinary free light chains (FLCs) indicated the probability of larger aggregates of FLCs. Size-exclusion chromatography, electrophoresis, analytical ultracentrifugation, and mass spectrometric studies of the serum revealed almost exclusively the presence of trimolecular aggregates of λ light chain dimers without other multimeric species.Conclusion: Monoclonal λ light chains may present as hexameric aggregates that cannot be cleared by renal excretion.
The monoclonal gammopathies
Kyle, Robert A.

Mayo Clinic

Clinical Chemistry | January 11, 2020 | Volume: 40 | Issue: 11 | Pages: 2154-2161

10.1093/clinchem/40.11.2154 Get It

Abstract Each monoclonal protein (M-protein, or myeloma protein) consists of two heavy polypeptide chains of the same class and subclass and two light polypeptide chains of the same type. Electrophoresis on cellulose acetate membranes is satisfactory for screening, although agarose electrophoresis is more sensitive for detecting small M-proteins. Immunoelectrophoresis should be performed when myeloma, macroglobulinemia, amyloidosis, or a related disorder is suspected. Immunofixation is useful when results of immunoelectrophoresis are equivocal. The recognition of a Bence Jones protein depends on the demonstration of a monoclonal light chain by immunoelectrophoresis or immunofixation of an adequately concentrated urine specimen. The differential diagnosis of an M-protein includes monoclonal gammopathy of undetermined significance (benign monoclonal gammopathy), multiple myeloma, solitary plasmacytoma of bone or extramedullary plasmacytoma, macroglobulinemia, lymphoma, chronic lymphocytic leukemia, and primary systemic amyloidosis.
330 Same-day Artificial Urinary Sphincter and Inflatable Penile Prosthesis Placement: Comparable Perioperative Outcomes
Carolan, Alexandra , Zell, Michael, Wolter, Christopher , Rose, Kyle

Mayo Clinic

The Journal of Sexual Medicine | January 1, 2020 | Volume: 17 | Issue: Supplement_1 | Pages: S83-S84

10.1016/j.jsxm.2019.11.150 Get It

Enhancing the R‐ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells
Gonsalves, Wilson I. , Jevremović, Dragan , Nandakumar, Bharat , Dingli, David , Lacy, Martha Q. , Hayman, Suzanne R. , Kapoor, Prashant , Leung, Nelson , Fonder, Amie , Hobbs, Miriam, Hwa, Yi L. , Muchtar, Eli , Warsame, Rahma , Kourelis, Taxiarchis , Russell, Stephen J. , Lust, John A., Lin, Yi , Siddiqui, Mustaqeem , Kyle, Robert A. , Kumar, Shaji , Dispenzieri, Angela , Leung, Nelson , Hwa, Yi Lisa, Warsame, Rahma , Kourelis, Taxiarchis , Russell, Stephen, Siddiqui, Mustaqeem A, Gertz, Morie A , Rajkumar, S Vincent , Muchtar, E , Gonsalves, Wilson , Russell, Stephen J , Jevremovic, Dragan , Siddiqui, Mustaqeem A , Dingli, David , Lin, Yi , Dispenzieri, Angela , Buadi, Francis K. , Go, Ronald S. , Gertz, Morie A. , Rajkumar, S. Vincent

Mayo Clinic

American Journal of Hematology | December 23, 2019 | Volume: 95 | Issue: 3 | Pages: 310-315

10.1002/ajh.25709 | PMID 31867775 Get It

AbstractOur prior studies identified the prognostic significance of quantifying cPCs by multiparametric flow cytometry (MFC) in newly diagnosed multiple myeloma (NDMM) patients. We evaluated if a similar quantification of cPCs could add prognostic value to the current R‐ISS classification of 556 consecutive NDMM patients seen at the Mayo Clinic, Rochester from 2009 to 2017. Those patients that had ≥5 cPCs/μL and either R‐ISS stage I or stage II disease were re‐classified as R‐ISS IIB stage for the purposes of this study. The median time to next therapy (TTNT) and overall survival (OS) for patients with ≥5 cPCs/μL at diagnosis was as follows: R‐ISS I (N = 110) ‐ 40 months and not reached; R‐ISS II (N = 69) ‐ 30 and 72 months; R‐ISS IIB (N = 96) ‐ 21 and 45 months and R‐ISS III (N = 281) ‐ 20 and 47 months respectively. Finally, ≥ 5 cPCs/μL retained its adverse prognostic significance in a multivariable model for TTNT and OS. Hence, quantifying cPCs by MFC can potentially enhance the R‐ISS classification of a subset of NDMM patients with stage I and II disease by identifying those patients with a worse than expected survival outcome.
Closing the Brief Case: Rat Bite Fever from a Kiss
Rodino, Kyle G. , Pethan, Kirsten D., Miller, Nathaniel E. , DeSimone, Daniel C. , Schuetz, Audrey N.

Mayo Clinic

Journal of Clinical Microbiology | December 20, 2019 | Volume: 58 | Issue: 1 | Pages: No page available

10.1128/jcm.00678-19 | PMID 31871057 Get It

The Brief Case: Rat Bite Fever from a Kiss
Rodino, Kyle G. , Pethan, Kirsten D., Miller, Nathaniel E. , DeSimone, Daniel C. , Schuetz, Audrey N.

Mayo Clinic

Journal of Clinical Microbiology | December 20, 2019 | Volume: 58 | Issue: 1 | Pages: No page available

10.1128/jcm.00677-19 | PMID 31871056 Get It